Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Rheumatol Int ; 39(10): 1829-1838, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31312887

ABSTRACT

Kawasaki disease (KD) has features that appear supporting an infectious cause with a secondary deranged inflammatory/autoimmune response. The association of KD in adults with human immunodeficiency virus infection and the presence of KD in patients with immunodeficiency disorders support the infectious theory. We present four KD patients associated with immunodeficiencies: one with X-linked agammaglobulinemia, one with HIV infection, and two with leukemia; one of these patients also had Down syndrome. We did a literature search to find out all reported cases of immunodeficiency with KD in children. In immunodeficiency disorders, the inability of the immune system to eradicate the pathogens coupled to an exaggerated inflammatory response, especially in chronic granulomatous disease, may lead to the development of KD. The study of patients with immunodeficiencies complicated with KD may shed light into the etiopathogenesis of the disease.


Subject(s)
Agammaglobulinemia/immunology , Genetic Diseases, X-Linked/immunology , HIV Infections/immunology , Immunocompromised Host , Leukemia/immunology , Mucocutaneous Lymph Node Syndrome/immunology , Adrenal Cortex Hormones/therapeutic use , Agammaglobulinemia/complications , Agammaglobulinemia/diagnosis , Agammaglobulinemia/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Child , Child, Preschool , Down Syndrome/complications , Genetic Diseases, X-Linked/complications , Genetic Diseases, X-Linked/diagnosis , Genetic Diseases, X-Linked/drug therapy , HIV Infections/complications , HIV Infections/diagnosis , HIV Infections/drug therapy , Humans , Immunoglobulins, Intravenous/therapeutic use , Infant , Leukemia/complications , Leukemia/diagnosis , Leukemia/drug therapy , Male , Mucocutaneous Lymph Node Syndrome/diagnosis , Mucocutaneous Lymph Node Syndrome/drug therapy , Risk Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL